South Korea · Delayed Price · Currency is KRW Daewoong Pharmaceutical Statistics
Total Valuation
KRX:069620 has a market cap or net worth of KRW 1.72 trillion. The enterprise value is 2.51 trillion.
| Market Cap | 1.72T |
| Enterprise Value | 2.51T |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
KRX:069620 has 11.51 million shares outstanding.
| Current Share Class | 11.51M |
| Shares Outstanding | 11.51M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 25.53% |
| Float | 5.38M |
Valuation Ratios
The trailing PE ratio is 8.80 and the forward PE ratio is 10.22. KRX:069620's PEG ratio is 0.10.
| PE Ratio | 8.80 |
| Forward PE | 10.22 |
| PS Ratio | 1.10 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 11.55 |
| PEG Ratio | 0.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.57, with an EV/FCF ratio of -59.27.
| EV / Earnings | 12.81 |
| EV / Sales | 1.60 |
| EV / EBITDA | 8.57 |
| EV / EBIT | 10.38 |
| EV / FCF | -59.27 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.24 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 3.36 |
| Debt / FCF | -19.59 |
| Interest Coverage | 15.67 |
Financial Efficiency
Return on equity (ROE) is 18.40% and return on invested capital (ROIC) is 11.45%.
| Return on Equity (ROE) | 18.40% |
| Return on Assets (ROA) | 5.63% |
| Return on Invested Capital (ROIC) | 11.45% |
| Return on Capital Employed (ROCE) | 11.02% |
| Weighted Average Cost of Capital (WACC) | 3.85% |
| Revenue Per Employee | 955.53M |
| Profits Per Employee | 119.13M |
| Employee Count | 1,644 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.64 |
Taxes
| Income Tax | -1.08B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.81% in the last 52 weeks. The beta is 0.16, so KRX:069620's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +29.81% |
| 50-Day Moving Average | 166,732.00 |
| 200-Day Moving Average | 157,321.00 |
| Relative Strength Index (RSI) | 40.39 |
| Average Volume (20 Days) | 27,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:069620 had revenue of KRW 1.57 trillion and earned 195.86 billion in profits. Earnings per share was 17,021.64.
| Revenue | 1.57T |
| Gross Profit | 822.53B |
| Operating Income | 195.51B |
| Pretax Income | 191.83B |
| Net Income | 195.86B |
| EBITDA | 246.58B |
| EBIT | 195.51B |
| Earnings Per Share (EPS) | 17,021.64 |
Balance Sheet
The company has 172.80 billion in cash and 829.39 billion in debt, with a net cash position of -656.59 billion or -57,063.54 per share.
| Cash & Cash Equivalents | 172.80B |
| Total Debt | 829.39B |
| Net Cash | -656.59B |
| Net Cash Per Share | -57,063.54 |
| Equity (Book Value) | 1.13T |
| Book Value Per Share | 87,438.70 |
| Working Capital | 143.53B |
Cash Flow
In the last 12 months, operating cash flow was 149.21 billion and capital expenditures -191.53 billion, giving a free cash flow of -42.33 billion.
| Operating Cash Flow | 149.21B |
| Capital Expenditures | -191.53B |
| Depreciation & Amortization | 51.07B |
| Net Borrowing | 172.76B |
| Free Cash Flow | -42.33B |
| FCF Per Share | -3,678.75 |
Margins
Gross margin is 52.36%, with operating and profit margins of 12.45% and 12.47%.
| Gross Margin | 52.36% |
| Operating Margin | 12.45% |
| Pretax Margin | 12.21% |
| Profit Margin | 12.47% |
| EBITDA Margin | 15.70% |
| EBIT Margin | 12.45% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 600.00, which amounts to a dividend yield of 0.40%.
| Dividend Per Share | 600.00 |
| Dividend Yield | 0.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.12% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.39% |
| Earnings Yield | 11.36% |
| FCF Yield | -2.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2012. It was a forward split with a ratio of 1.03.
| Last Split Date | Dec 27, 2012 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:069620 has an Altman Z-Score of 2.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.32 |
| Piotroski F-Score | 5 |